Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell Disease

1 May 2023

Abstract excerpt

Background: Pain is a common cause of hospitalization in sickle cell disease (SCD) patients. Failure to effectively control pain remains a challenge in patient care. Materials & methods: The authors conducted a cross-sectional study to determine the effect of CYP2D6 and UGT2B7 polymorphisms on pain management in 106 Zimbabwean SCD patients. Participant information was collected on a questionnaire. Genotyping was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Hemoglobinopathies and Related Disorders
Share to Pharmacological Effects and Toxicity Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37248824
DOI: 10.2217/pgs-2023-0045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of Pain Management in Zimbabwean Patients With Sickle Cell DiseasePMID 37248824Read ↗

An Expert Review of Pharmacogenomics of Sickle Cell Disease Therapeutics: Not Yet Ready for Global Precision MedicineSemantic proximity Read ↗

Pharmacogenetics of morphine: Potential implications in sickle cell disease.Semantic proximity Read ↗

CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) programSemantic proximity Read ↗

Cytochrome P450 2D6 polymorphisms and predicted opioid metabolism in African American children with sickle cell disease.Semantic proximity Read ↗

Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.Semantic proximity Read ↗

Preemptive Genotyping of CYP2C8 and CYP2C9 Allelic Variants Involved in NSAIDs Metabolism for Sickle Cell Disease Pain Management.Semantic proximity Read ↗

Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.Semantic proximity Read ↗

Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review.Semantic proximity Read ↗

Pain and genetics.Semantic proximity Read ↗

Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.Semantic proximity Read ↗

A Review of the Role of Genetic Testing in Pain MedicineSemantic proximity Read ↗

HUMAN STUDY COMT and DRD3 haplotype-associated pain intensity and acute care utilization in adult sickle cell disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.